@article{476966cab47f48e3b16f01880fb5c763,
title = "Cancer nanomedicines: oversold or underappreciated?",
keywords = "Cancer nanomedicines, Clinical translation, Clinical trials, Combination treatment, Drug delivery, Drug targeting, EPR effect, Triggered release",
author = "\{van der Meel\}, Roy and Twan Lammers and Hennink, \{Wim E.\}",
note = "Funding Information: R van der Meel is supported by a Veni STW Grant (14385) of the Netherlands Organization for Scientific Research (NWO). T Lammers is supported by the European Research Council [StG-309495, PoC-680882] and by the German Research Foundation [LA 2937/1-2].",
year = "2017",
month = jan,
day = "2",
doi = "10.1080/17425247.2017.1262346",
language = "English",
volume = "14",
pages = "1--5",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Taylor and Francis Ltd.",
number = "1",
}